Skip to main content
HairCited

Medical and procedural treatment of androgenetic alopecia - Where are we?

Nathalie Y Ly, Sophia Fruechte, Maria K Hordinsky, Neil Sadick, Suleima Arruda et al.
Review Journal of the American Academy of Dermatology 2023 20 citações
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D37591565'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Tipo de Estudo
Review
População
Patients with androgenetic alopecia
Intervenção
Medical and procedural treatment of androgenetic alopecia - Where are we? LDOM, finasteride, PRP, photobiomodulation
Comparador
None
Desfecho Primário
AGA treatment advances overview
Direção do Efeito
Positive
Risco de Viés
Unclear

Abstract

Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.

Resumo Rápido

None

Used In Evidence Reviews

Similar Papers